NASDAQ:ONCO Onconetix (ONCO) Stock Price, News & Analysis $0.13 0.00 (-1.34%) (As of 09/6/2024 08:49 PM ET) Add Compare Share Share Today's Range$0.12▼$0.1350-Day Range$0.13▼$0.2252-Week Range$0.10▼$0.78Volume285,500 shsAverage Volume6.55 million shsMarket Capitalization$2.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get Onconetix alerts: Email Address Ad Deal MakerThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.Learn more about this much-needed advancement and investment opportunity here. About Onconetix Stock (NASDAQ:ONCO)Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.Read More ONCO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ONCO Stock News HeadlinesJuly 19, 2024 | benzinga.comOnconetix (NASDAQ:ONCO) Stock, Short Interest ReportJuly 19, 2024 | benzinga.comOnconetix (NASDAQ:ONCO) Stock Quotes, Forecast and News SummarySeptember 9, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.July 18, 2024 | investorplace.comWhy Is Onconetix (ONCO) Stock Up 37% Today?July 15, 2024 | globenewswire.comOnconetix Announces Closing of Warrant Exercise for $1.11 Million Gross ProceedsJuly 11, 2024 | globenewswire.comOnconetix Announces Exercise of Warrants for $1.11 Million Gross ProceedsMay 19, 2024 | finance.yahoo.comOnconetix, Inc. (ONCO) Latest Stock News & Headlines - Yahoo FinanceMay 17, 2024 | msn.comWhy Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day SessionSeptember 9, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.April 29, 2024 | finanznachrichten.deImmunovia AB: Immunovia Publishes Interim Report for January-March 2024April 29, 2024 | finance.yahoo.comImmunovia Publishes Interim Report for January-March 2024April 28, 2024 | finance.yahoo.comOnconetix, Inc. (ONCO) Latest Press Releases & Corporate News - Yahoo FinanceApril 17, 2024 | finance.yahoo.comOnconetix, Inc. (ONCO)April 15, 2024 | finance.yahoo.comBlue Water Vaccines Inc (J4T.SG)March 25, 2024 | bizjournals.comWorkhorse Group clings to Nasdaq listing, plans reverse split amid prolonged stock slumpFebruary 21, 2024 | sg.finance.yahoo.comImmunovia Publishes Full Year Report for 2023February 21, 2024 | finanznachrichten.deImmunovia AB: Immunovia Publishes Full Year Report for 2023February 14, 2024 | finanznachrichten.deOnconetix, Inc.: Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of DirectorsSee More Headlines Receive ONCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Onconetix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/08/2024Next Earnings (Estimated)11/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ONCO Previous SymbolNASDAQ:ONCO CUSIPN/A CIK1782107 Webwww.bwbioinc.com Phone513-620-4101FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-37,410,000.00 Net MarginsN/A Pretax Margin-6,040.49% Return on Equity-1,472.15% Return on Assets-56.66% Debt Debt-to-Equity Ratio0.08 Current Ratio0.29 Quick Ratio0.28 Sales & Book Value Annual Sales$1.46 million Price / Sales1.91 Cash FlowN/A Price / Cash FlowN/A Book Value$0.08 per share Price / Book1.57Miscellaneous Outstanding Shares22,328,000Free Float17,974,000Market Cap$2.80 million OptionableN/A Beta3.65 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Bruce Harmon (Age 66)Chief Financial Officer Comp: $349.38kDr. Ralph Schiess Ph.D. (Age 45)Interim CEO & Chief Science Officer Dr. Brian Price Ph.D.Head of Technology StrategyMr. Frank A. Jaeger M.A. (Age 54)M.B.A., Senior VP of Marketing & Business Development Mr. Andrew D. Skibo Ph.D.Global Head of Biologics OperationsMr. Theodore Scott YohoHead of Business DevelopmentDr. Ali I. Fattom Ph.D.Head of Science & DiscoveryDr. Jay Newmark M.B.A.M.D., Chief Medical OfficerMr. Christian Bruhlmann (Age 47)Chief Strategy Officer & GM of Europe Dr. Donald L. Very Jr.Ph.D., Senior VP of Commercial Research & DevelopmentMore ExecutivesKey CompetitorsPurple BiotechNASDAQ:PPBTAddex TherapeuticsNASDAQ:ADXNRedHill BiopharmaNASDAQ:RDHLForte BiosciencesNASDAQ:FBRXPHAXIAM TherapeuticsNASDAQ:PHXMView All CompetitorsInstitutional OwnershipZurcher Kantonalbank Zurich Cantonalbank Bought 306,079 shares on 7/29/2024Ownership: 1.371%View All Institutional Transactions ONCO Stock Analysis - Frequently Asked Questions How have ONCO shares performed this year? Onconetix's stock was trading at $0.1980 at the beginning of the year. Since then, ONCO shares have decreased by 36.7% and is now trading at $0.1254. View the best growth stocks for 2024 here. Who are Onconetix's major shareholders? Onconetix's top institutional investors include Zurcher Kantonalbank Zurich Cantonalbank (1.37%). How do I buy shares of Onconetix? Shares of ONCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ONCO) was last updated on 9/9/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredForget polls, focus on these 5 tickersWith all the geopolitical tensions in the world… all the inflation… all the expectations of a new round of Fed...StockEarnings | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis Crypto Coin Could 10x FASTER Than BitcoinA shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconetix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Onconetix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
